Active substanceSodium HeparinSodium Heparin
Similar drugsTo uncover
  • Heparin
    solution in / in PC 
    ALVILS, LTD.     Russia
  • Heparin
    solution in / in PC 
    BINERGIYA, CJSC     Russia
  • Heparin
    solution in / in PC 
    ELFA NPC, CJSC     Russia
  • Heparin
    gel externally 
  • Heparin
    gel externally 
  • Heparin
    solution in / in PC 
  • Heparin
    solution in / in PC 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Heparin
    solution in / in PC 
  • Heparin
    solution in / in PC 
  • Heparin
    solution for injections 
    SYNTHESIS, OJSC     Russia
  • Heparin
    solution in / in PC 
  • Heparin
    gel externally 
    GREEN DUBRAVA, CJSC     Russia
  • Heparin
    gel externally 
  • Heparin 1000
    gel externally 
    ATOLL, LLC     Russia
  • Heparin J
    solution in / in PC 
    JODAS EKSPOIM, LLC     Russia
  • Sodium Heparin
    solution in / in PC 
    ELLARA, LTD.     Russia
  • Sodium Heparin
    solution in / in PC 
    INDUKERN-RUS, OOO     Russia
  • Sodium Heparin
    solution in / in PC 
  • Heparin-Akrihin 1000
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • Heparin-sodium Brown
    solution in / in PC 
  • Heparin-Ferein®
    solution for injections 
    BRYNTSALOV-A, CJSC     Russia
  • Lavenum®
    gel externally 
    POLLO, LLC     Russia
  • Lyoton® 1000
    gel externally 
  • Trombles®
    gel externally 
    NIZHFARM, JSC     Russia
  • Thrombogel 1000
    gel externally 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Dosage form: & nbspgel for external use.
    Composition:per 100 g:
    Active substance:
    heparin sodium with an activity of 120 IU / mg in terms of dry matter - 0.833 g;
    Excipients: carbomer 940 (carbopol 980) 1.3 g, methylprahydroxybenzoate (nipagin) 0.15 g, trometamol 1.0 g, lavender oil 0.1 g, polyester PE 240 5.0 g, ethyl alcohol 95% (ethanol) - 30.0 g, purified water - 61.617 g.
    Description:Colorless or slightly yellowish tinge almost transparent gel with a specific odor. Opalescence is allowed.
    Pharmacotherapeutic group:Anticoagulant is a direct action for topical application.
    ATX: & nbsp

    B.01.A.B.01   Heparin

    Pharmacodynamics:Direct anticoagulant, has anti-inflammatory, antiproliferative, anti-edematous and analgesic effect. Reduces platelet aggregation, binds to antithrombin III, preventing the passage of prothrombin in thrombin. Oppresses the activity of thrombin.Reduces the activity of hyaluronidase, increases the fibrinolytic properties of the blood. Gel improves microcirculation and activates tissue metabolism, thereby accelerating the processes of resorption of hematomas and thrombi, eventually restoring the permeability of veins, clinically it is accompanied by a pronounced analgesic and anti-inflammatory effect.
    Pharmacokinetics:An insignificant amount of heparin is absorbed from the surface of the skin into the systemic circulation. The maximum concentration of the drug in the blood is noted 8 hours after the application. The elimination of heparin, mainly occurs through the kidneys, half-life of 12 hours.
    Indications:- thrombophlebitis of superficial veins;
    - localized infiltrates and edema of soft tissues;
    - subcutaneous hematomas (including hematomas after phlebectomy);
    - injuries and bruises of joints, tendons, muscle tissue.
    Contraindications:hypersensitivity to the components of the drug;
    - ulcerative necrotic changes of the skin in places of supposed application of gel;
    - traumatic violation of the integrity of the skin;
    - Children's age (the experience of using the drug is limited).
    Carefully:Increased tendency to bleeding, thrombocytopenia.
    Pregnancy and lactation:It is possible to use the drug during pregnancy and lactation, if the potential benefit to the mother exceeds the risk to the fetus and the baby.
    Dosing and Administration:Outwardly.
    Thrombophlebitis of superficial veins.
    3-5 cm gel rubbing movements are applied to the skin on the affected area 1-3 times a day. For thrombosis of hemorrhoidal veins, pads with applied gel are used.
    Localized infiltrates and soft tissue swelling.
    3-5 cm gel rubbing movements are applied to the skin on the affected area 1-3 times a day.
    Subcutaneous hematomas (including hematomas after phlebectomy).
    3-5 cm gel rubbing movements are applied to the skin on the affected area 1-3 times a day.
    Injuries and bruises of joints, tendons, muscle tissue.
    3-5 cm gel rubbing movements are applied to the skin on the affected area 1-3 times a day.
    Side effects:Allergic reactions, skin hyperemia.
    Overdose:Overdose is unlikely due to low absorption of the components of the gel.
    Interaction:It is not recommended to mix with other agents for external use, do not prescribe locally simultaneously with non-steroidal anti-inflammatory drugs, tetracyclines, antihistamines.The combined use of a gel with oral anticoagulants can cause prolonged prothrombin time.
    Special instructions:It is not recommended for bleeding, if there are local purulent processes, and also applied to open wounds, mucous membranes. Use with extreme caution with increased vascular permeability. The use of the gel is not recommended for deep venous thrombosis.
    Effect on the ability to drive transp. cf. and fur:The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:Gel for external use 1000 IU / g.
    Packaging:For 30 g, 50 g or 100 g in an aluminum tube. Tubu together with instructions for use are placed in a pack of cardboard.
    Storage conditions:At a temperature not higher than 25 ° C. Keep out of the reach of children.
    Shelf life:2 years.
    Do not use after the expiration date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001895
    Date of registration:02.11.2012
    The owner of the registration certificate:TATHIMFARMPREPARATY, JSC TATHIMFARMPREPARATY, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp2016-01-09
    Illustrated instructions
      Instructions
      Up